Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_assertion description "[The +936C allele, which is also hypothesized to increase VEGF expression, was not clearly associated with invasive breast cancer (OR 1.21, 95% CI 0.88-1.67 for +936 CC versus TT/CT), but it was associated with reduced risk for in situ cancer (OR 0.59, 95% CI 0.37-0.93 for CC versus TT/CT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_assertion evidence source_evidence_literature NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_assertion SIO_000772 16613616 NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_assertion wasDerivedFrom befree-20140225 NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_assertion wasGeneratedBy ECO_0000203 NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP525587.RAJjQ6QatN20NdLfWMKi8_3uW9yb0IAPKX-U8TRmvL6W0130_provenance.